Focal acne during topical tacrolimus therapy for vitiligo [15]

Archives of Dermatology

Volumn 143, Issue 9, 2007, Pages 1223-1224

  Bakos, Lucio ^a   Bakos, Renato Marchiori ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DESONIDE; DOXYCYCLINE; TACROLIMUS;

ACNE; ADULT; CASE REPORT; COMEDO; FEMALE; HUMAN; LETTER; PAPULE; PRIORITY JOURNAL; PUSTULE; SKIN PIGMENTATION; TREATMENT OUTCOME; VITILIGO;

ACNE VULGARIS; ADOLESCENT; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS; VITILIGO;

EID: 34548818171     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.9.1223     Document Type: Letter

References (5)

1. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol. 2003;139(5):571-574.
2. Prats Caelles I, Pinto PH, Casado ELA, Laguna RL. Focal hypertrichosis during topical tacrolimus therapy for childhood vitiligo. Pediatr Dermatol. 2005;22(1):86-87.
3. Antille C, Saurat JH, Lübbe J. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol. 2004;140(4):457-460.
4. El Sayed F, Ammoury A, Dhaybi R, et al. Rosaceiform eruption to pimecrolimus. J Am Acad Dermatol. 2006;54(3):548-549.
5. Soter NA, Fleiscer AB, Webster GF, et al. Tacrolimus ointment for the treatment treatment of atopic dermatitis in adults, II: safety. J Am Acad Dermatol. 2001;44(1)(suppl):S39-S46.